Cargando…

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF

The segmentation of the in vitro fertilization (IVF) cycle, consisting of the freezing of all embryos and the postponement of embryo transfer (ET), has become popular in recent years, with the main purpose of preventing ovarian hyperstimulation syndrome (OHSS) in patients with high response to contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carosso, Andrea Roberto, Canosa, Stefano, Gennarelli, Gianluca, Sestero, Marta, Evangelisti, Bernadette, Charrier, Lorena, Bergandi, Loredana, Benedetto, Chiara, Revelli, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998839/ https://www.ncbi.nlm.nih.gov/pubmed/33800021 http://dx.doi.org/10.3390/ph14030228

Ejemplares similares

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Dual Trigger with Gonadotropin Releasing Hormone Agonist and Human Chorionic Gonadotropin of Fresh Autologous Cycles in High Responders: A Systematic Review
por: Vyrides, Andreas A, et al.
Publicado: (2022)

Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization
por: Bergandi, Loredana, et al.
Publicado: (2020)

Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
por: Mennini, F. S., et al.
Publicado: (2018)

Effect of intrauterine injection of human chorionic gonadotropin before fresh embryo transfer on IVF and ICSI outcomes: a meta-analysis
por: Hou, Wenhui, et al.
Publicado: (2018)

The earlier the initiation of gonadotropin in poor responders in luteal phase stimulation protocols, the better
por: Huang, Jia, et al.
Publicado: (2022)

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome
por: Inamdar, Dattaprasad B, et al.
Publicado: (2012)

Subdose of human chorionic gonadotropin applied at the Hou Hai acupoint on follicular dynamics and luteal development in donkeys
por: Ribeiro, Márcio de Oliveira, et al.
Publicado: (2020)

Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population
por: Revelli, Alberto, et al.
Publicado: (2015)

Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone
por: Canosa, Stefano, et al.
Publicado: (2022)

Women in Advanced Reproductive Age: Are the Follicular Output Rate, the Follicle-Oocyte Index and the Ovarian Sensitivity Index Predictors of Live Birth in an IVF Cycle?
por: Carosso, Andrea Roberto, et al.
Publicado: (2022)

Experimental Production of Gynecomastia with Chorionic Gonadotropin
por: Klatskin, Gerald, et al.
Publicado: (1952)

Chorionic gonadotropin and uterine dialogue in the primate
por: Cameo, Paula, et al.
Publicado: (2004)

IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN CHORIONIC GONADOTROPIN
por: Midgley, A. R., et al.
Publicado: (1962)

Human Chorionic Gonadotropin and Breast Cancer
por: Schüler-Toprak, Susanne, et al.
Publicado: (2017)

The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS
por: Eftekhar, Maryam, et al.
Publicado: (2016)

Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation—A Retrospective Proof-of-Concept Study
por: Lawrenz, Barbara, et al.
Publicado: (2018)

Effect of a Combination of Myo-Inositol, Alpha-Lipoic Acid, and Folic Acid on Oocyte Morphology and Embryo Morphokinetics in non-PCOS Overweight/Obese Patients Undergoing IVF: A Pilot, Prospective, Randomized Study
por: Canosa, Stefano, et al.
Publicado: (2020)

Fertility Rates of Ewes Treated with Medroxyprogesterone and Injected with Equine Chorionic Gonadotropin plus Human Chorionic Gonadotropin in Anoestrous Season
por: Santos, I. W., et al.
Publicado: (2010)

The relationship between the variants in the 5′-untranslated regions of equine chorionic gonadotropin genes and serum equine chorionic gonadotropin levels
por: Liu, ShuQin, et al.
Publicado: (2017)

ICSI versus Conventional IVF in Women Aged 40 Years or More and Unexplained Infertility: A Retrospective Evaluation of 685 Cycles with Propensity Score Model
por: Gennarelli, Gianluca, et al.
Publicado: (2019)

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
por: Bagchus, Wilhelmina, et al.
Publicado: (2017)

Human Chorionic Gonadotropin: The Pregnancy Hormone and More
por: Theofanakis, Charalampos, et al.
Publicado: (2017)

Human Chorionic Gonadotropin and Early Embryogenesis: Review
por: d’Hauterive, Sophie Perrier, et al.
Publicado: (2022)

Production of Mare Chorionic Girdle Organoids That Secrete Equine Chorionic Gonadotropin
por: Thompson, Riley E., et al.
Publicado: (2023)

Reproductive and Obstetric Outcomes Following a Natural Cycle vs. Artificial Endometrial Preparation for Frozen–Thawed Embryo Transfer: A Retrospective Cohort Study
por: Carosso, Andrea Roberto, et al.
Publicado: (2023)

Gonadotropin-releasing hormone agonist triggering with concomitant administration of low doses of human chorionic gonadotropin or a freeze-all strategy in high responders
por: Karacan, Meric, et al.
Publicado: (2017)

Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF
por: Biasoni, Valentina, et al.
Publicado: (2011)

Effect of lithium chloride on the luteal steroidogenesis in gonadotropin-stimulated rat
por: Khodadadi, Maryam, et al.
Publicado: (2012)

Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles
por: Albeitawi, Soha, et al.
Publicado: (2022)

New discoveries on the biology and detection of human chorionic gonadotropin
por: Cole, Laurence A
Publicado: (2009)

Management of Nonpregnant Women with Elevated Human Chorionic Gonadotropin
por: Schmid, Bernd C., et al.
Publicado: (2013)

Endometrial carcinoma with ectopic human chorionic gonadotropin expression
por: Lee, Regina, et al.
Publicado: (2015)

Human Chorionic Gonadotropin Influences Systemic Autoimmune Responses
por: De, Alpana, et al.
Publicado: (2018)

Chorionic gonadotropin: Ovarian hyperstimulation syndrome: case report
Publicado: (2021)

Independent value of serum β-human chorionic gonadotropin in predicting early pregnancy loss risks in IVF/ICSI cycles
por: Wang, Liyan, et al.
Publicado: (2022)

Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial
por: Krishna, Deepika, et al.
Publicado: (2016)

Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
por: Liu, Ying, et al.
Publicado: (2021)

Single Dose Gonadotropin-Releasing Hormone Agonist Luteal Support in Fresh Embryo Transfer: Variation in Timing, Type, and Dosage
por: Abu, Muhammad Azrai, et al.
Publicado: (2022)

Total human chorionic gonadotropin is a more suitable diagnostic marker of gestational trophoblastic diseases than the free β-subunit of human chorionic gonadotropin
por: Usui, Hirokazu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a84pdml9p99ct091mkbuev8bvc